RPHM Old Financials

RPHM Old Stock Summary

RPHM Old competes with Prime Medicine,, Ginkgo Bioworks, Royalty Pharma, Immix Biopharma, and Cns Pharmaceuticals. Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

RPHM Old Key Financial Ratios

RPHM Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining RPHM Old's current stock value. Our valuation model uses many indicators to compare RPHM Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RPHM Old competition to find correlations between indicators driving RPHM Old's intrinsic value. More Info.RPHM Old is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value RPHM Old by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.